This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Brain glioblastoma and astrocytoma
C3_GBM_ASTROCYTOMA
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditions
|
578 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
578 |
4. Check minimum number of eventsNone |
578 |
5. Include endpoints |
578 |
6. Filter based on genotype QC (FinnGen only) |
578 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- C
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Brain glioblastoma and astrocytoma
based on the number of shared cases.
Similar with more cases:
- Brain glioblastoma and astrocytoma, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of brain
- Malignant neoplasm of eye, brain and central nervous system
- Malignant neoplasm of brain, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of eye, brain and central nervous system, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 578 | 248 | 330 |
| Unadjusted period prevalence (%) | 0.12 | 0.08 | 0.15 |
| Median age at first event (years) | 62.19 | 61.09 | 63.01 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 546
- Matched controls
- 5459
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
1846.3
323.0
413
9
L01AX03
ATC
temozolomide; systemic
1377.2
323.0
365
8
130
Kela drug reimbursment
Malignant tumour
73.7
323.0
413
220
H02AB02
ATC
dexamethasone; systemic
98.2
323.0
456
267
N03AX14
ATC
levetiracetam; systemic
101.7
266.7
283
57
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
51.4
239.5
292
119
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
34.6
219.4
301
187
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
94.5
205.4
221
39
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
408.0
198.3
188
7
C71.23
ICD-10 Finland
Malignant tumor of temporal lobe grade IV glioma
+∞
167.6
152
*
A04AA02
ATC
granisetron; systemic, transdermal
27.0
158.1
228
141
WF002
NOMESCO Finland
Radical radiotherapy
29.2
152.2
213
117
9440/3-C71.9
ICD-O-3
Glioblastoma, NOS, of brain, NOS
+∞
137.4
126
*
ZXC95
NOMESCO Finland
Use of surgical navigator
100.0
136.8
147
20
C71.13
ICD-10 Finland
Malignant tumor of frontal lobe grade IV glioma
+∞
135.2
124
*
C71.20
ICD-10 Finland
Malignant tumor in temporal lobe without histology
1614.8
134.2
125
*
C71.10
ICD-10 Finland
Malignant tumor in frontal lobe without histology
544.0
133.1
127
*
A03FA01
ATC
metoclopramide; systemic, rectal
10.8
132.0
323
643
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
129.0
130.1
136
14
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
269.3
126.7
125
6
Z51.5
ICD-10 Finland
Palliative care
19.2
115.5
186
143
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
39.8
114.5
145
49
WF003
NOMESCO Finland
Adjuvant radiotherapy
25.9
113.8
163
88
C71.90
ICD-10 Finland
Malignant tumor in unspecified localization in the brain without histology
347.3
113.7
111
*
9440/3-C71.2
ICD-O-3
Glioblastoma, NOS, of temporal lobe
+∞
110.2
102
*
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
40.8
98.6
124
39
C71.2
ICD-10 Finland
Malignant neoplasm: Temporal lobe
1087.2
96.0
91
*
C71.1
ICD-10 Finland
Malignant neoplasm: Frontal lobe
1072.9
94.9
90
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
25.6
92.5
132
67
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
42.5
92.4
115
34
9440/3-C71.1
ICD-O-3
Glioblastoma, NOS, of frontal lobe
+∞
92.4
86
*
YX8VG
NOMESCO Finland
Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy
497.9
87.8
85
*
AA1AD
NOMESCO Finland
CT of head and brain
6.8
87.7
291
782
AAG00
NOMESCO Finland
Stereotactic intracranial biopsy
932.9
83.9
80
*
C71.33
ICD-10 Finland
Malignant tumor of parietal lobe grade IV glioma
+∞
81.3
76
*
XX3DW
NOMESCO Finland
Time consuming IT work
9.4
79.9
185
283
C71.11
ICD-10 Finland
Malignant tumor of frontal lobe grade II glioma
409.3
73.6
72
*
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
213.4
73.1
74
*
N03AX18
ATC
lacosamide; systemic
137.9
68.7
72
6
N03AF02
ATC
oxcarbazepine; oral
18.7
68.4
108
71
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
6.3
67.3
215
509
C71.30
ICD-10 Finland
Malignant tumor in parietal lobe without histology
371.8
66.0
65
*
A04AA01
ATC
ondansetron; systemic, rectal
10.7
65.7
136
164
ZX095
NOMESCO Finland
Combined chemoradiotherapy
87.2
62.7
69
9
D43.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Central nervous system, unspecified
+∞
61.6
58
*
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
9.2
61.6
140
198
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
76.1
59.8
67
10
ZXC40
NOMESCO Finland
Use of ultrasound
83.0
59.6
66
9
C71.21
ICD-10 Finland
Malignant tumor of temporal lobe grade II glioma
607.7
56.7
55
*
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
10.7
55.9
114
131
R56.8
ICD-10 Finland
Other and unspecified convulsions
10.4
55.3
115
137
WX882
NOMESCO Finland
High dependency care
16.6
51.3
84
59
9400/3-C71.9
ICD-O-3
Astrocytoma, NOS, of brain, NOS
+∞
50.8
48
*
ZX050
NOMESCO Finland
Stereotactic radiotherapy
58.8
49.8
58
11
9440/3-C71.3
ICD-O-3
Glioblastoma, NOS, of parietal lobe
+∞
49.8
47
*
9400/3-C71.1
ICD-O-3
Astrocytoma, NOS, of frontal lobe
+∞
48.7
46
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
13.1
47.8
87
78
C71.3
ICD-10 Finland
Malignant neoplasm: Parietal lobe
+∞
47.6
45
*
D43.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, unspecified
498.4
47.0
46
*
N74
ICPC
Malignant neoplasm nervous system
498.4
47.0
46
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
9.4
45.6
99
125
ZXM40
NOMESCO Finland
Use of fluorescent substance
474.6
44.9
44
*
C71.83
ICD-10 Finland
Overall malignant tumor of the brain grade IV glioma
462.8
43.8
43
*
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
163.1
43.5
45
*
A02BC02
ATC
pantoprazole; systemic
3.8
42.4
425
2605
C71.99
ICD-10 Finland
Malignant tumor in unspecified localization in the brain other or unspecified histology
119.4
41.4
44
*
XA800
NOMESCO Finland
Neuropsychological investigation
10.2
39.9
82
93
C71.29
ICD-10 Finland
Malignant tumor in temporal lobe other or unspecified histology
416.0
39.6
39
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
3.4
37.6
267
1210
AA1BD
NOMESCO Finland
Extensive CT of head and brain
15.4
37.1
62
45
G40.9
ICD-10 Finland
Epilepsy, unspecified
10.1
37.0
76
86
N03AB02
ATC
phenytoin; systemic
28.2
36.1
49
19
N02AA05
ATC
oxycodone; systemic
4.5
34.5
141
396
N05CD08
ATC
midazolam; nasal, systemic
15.5
33.7
56
40
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
16.2
32.5
53
36
A28
ICPC
Limited function/disability NOS
4.1
30.3
133
395
C71.22
ICD-10 Finland
Malignant tumor of temporal lobe grade III glioma
319.2
30.1
30
*
C71.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of brain
+∞
29.4
28
*
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
46.6
29.0
35
8
WZC30
NOMESCO Finland
Teaching
3.9
28.9
134
416
C71.12
ICD-10 Finland
Malignant tumor of frontal lobe grade III glioma
295.9
28.0
28
*
WX402
NOMESCO Finland
General anaesthesia
3.6
27.6
148
517
C71.93
ICD-10 Finland
Malignant tumor in an unspecified localization in the brain grade IV glioma
284.4
27.0
27
*
N05BA09
ATC
clobazam; oral
101.9
26.9
29
*
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
31.0
26.6
35
12
WX872
NOMESCO Finland
Intensive care
6.5
26.5
72
125
ZX070
NOMESCO Finland
Intensity modified radiotherapy
13.9
26.1
45
35
C71.19
ICD-10 Finland
Malignant tumor of frontal lobe other or unspecified histology
272.9
25.9
26
*
C71.00
ICD-10 Finland
Malignant tumor of the cerebrum except lobes and ventricles without histology
272.9
25.9
26
*
AAA10
NOMESCO Finland
Biopsy through craniotomy
141.7
25.8
27
*
C71.40
ICD-10 Finland
Malignant tumor of the occipital lobe without histology
+∞
24.1
23
*
A98
ICPC
Health maint/preventive medicine
0.3
24.1
383
4795
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
17.2
23.5
37
23
R90.8
ICD-10 Finland
Other abnormal findings on diagnostic imaging of central nervous system
26.0
23.3
32
13
C71.43
ICD-10 Finland
Malignant tumor of the occipital lobe grade IV glioma
+∞
23.1
22
*
C71.80
ICD-10 Finland
Overall malignant tumor of the brain without histology
+∞
22.0
21
*
9400/3-C71.2
ICD-O-3
Astrocytoma, NOS, of temporal lobe
+∞
22.0
21
*
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.2
21.0
124
456
H53.4
ICD-10 Finland
Visual field defects
9.1
20.8
44
52
D43.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, infratentorial
218.0
20.7
21
*
G40.10
ICD-10 Finland
Simple partial seizures
28.3
20.2
27
10
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
24.5
20.1
28
12
C71.03
ICD-10 Finland
Malignant tumor of cerebellum except lobes and ventricles grade IV glioma
+∞
19.9
19
*
9440/3-C71.0
ICD-O-3
Glioblastoma, NOS, of cerebrum
+∞
19.9
19
*
C71.01
ICD-10 Finland
Malignant tumor of cerebellum except lobes and ventricles grade II glioma
207.2
19.7
20
*
N76
ICPC
Neoplasm nervous system unspecified
207.2
19.7
20
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.8
19.6
151
658
A79
ICPC
Malignancy NOS
19.1
19.3
29
16
N03AG01
ATC
valproic acid; systemic, rectal
4.6
18.9
69
168
C71.31
ICD-10 Finland
Malignant tumor of the parietal lobe grand II glioma
+∞
18.9
18
*
N05CF01
ATC
zopiclone; oral
2.4
18.4
204
1085
XX9BW
NOMESCO Finland
Submitting image material and/or investigation material to authority or other institution
20.2
18.4
27
14
G40.19
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
29.9
17.5
23
8
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
16.6
17.2
27
17
C71.9
ICD-10 Finland
Malignant neoplasm: Brain, unspecified
93.0
16.7
18
*
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
11.7
16.4
30
27
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
7.8
15.7
36
49
G41.9
ICD-10 Finland
Status epilepticus, unspecified
22.9
15.7
22
10
R90.0
ICD-10 Finland
Intracranial space-occupying lesion
164.5
15.6
16
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
6.8
15.2
38
59
WX408
NOMESCO Finland
General anesthesy, balanced
2.3
15.2
179
960
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
14.5
15.2
25
18
R4120
NOMESCO Finland
Occupational therapy
3.9
15.0
63
175
TPH04
NOMESCO Finland
Cathetrisation of vein
2.4
14.9
147
720
9440/3-C71.8
ICD-O-3
Glioblastoma, NOS, of overlapping lesion of brain
+∞
14.6
14
*
N03AX23
ATC
brivaracetam; systemic
154.0
14.5
15
*
ZSA00
NOMESCO Finland
Procedure related to previous procedure classified in chapter A
37.1
14.5
18
5
N03AF01
ATC
carbamazepine; oral, rectal
4.6
14.5
51
120
WC105
NOMESCO Finland
Simple cytostatic therapy of local tumor recidive
30.9
14.0
18
6
183
Kela drug reimbursment
Lamotrigin and topiramate
18.1
13.9
21
12
R4150
NOMESCO Finland
Neuropsychological rehabilitation
14.1
13.8
23
17
C71.32
ICD-10 Finland
Malignant tumor of parietal lobe grade III glioma
+∞
13.6
13
*
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
11.9
13.4
24
21
WF004
NOMESCO Finland
Palliative radiotherapy
8.4
13.0
28
35
WF029
NOMESCO Finland
Radiotherapy of local residive tumor
15.9
12.7
20
13
9440/3-C71.4
ICD-O-3
Glioblastoma, NOS, of occipital lobe
+∞
12.5
12
*
WX704
NOMESCO Finland
Intubation
3.4
12.5
61
192
H02AB09
ATC
hydrocortisone; systemic
7.2
12.3
29
42
YX8AD
NOMESCO Finland
Stereotactic CT examination for dose design of radiotherapy
66.4
11.6
13
*
N05BA04
ATC
oxazepam; oral
2.2
11.5
142
765
C71.39
ICD-10 Finland
Malignant tumor of parietal lobe other or unspecified histology
122.5
11.5
12
*
XA400
NOMESCO Finland
EEG
28.7
10.8
14
5
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
13.2
10.7
18
14
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.1
10.6
60
210
C71.4
ICD-10 Finland
Malignant neoplasm: Occipital lobe
112.1
10.5
11
*
G40.11
ICD-10 Finland
Simple partial epileptic seizure that develops into a complex partial seizure
40.9
10.0
12
*
R4130
NOMESCO Finland
Speech therapy
5.9
9.9
27
48
C71.81
ICD-10 Finland
Overall malignant tumor of the brain grade II glioma
101.7
9.4
10
*
R47.0
ICD-10 Finland
Dysphasia and aphasia
8.3
9.4
20
25
G93.6
ICD-10 Finland
Cerebral oedema
+∞
9.4
9
*
TPH07
NOMESCO Finland
Cathetrisation of artery
2.6
9.3
69
287
XF400
NOMESCO Finland
ECG with 12 standard connections
2.2
9.2
104
535
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
3.3
9.2
45
143
R4110
NOMESCO Finland
Physiotherapy
1.9
9.1
158
963
G41.2
ICD-10 Finland
Complex partial status epilepticus
37.3
9.0
11
*
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
0.4
8.9
32
791
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
9.7
8.8
17
18
Z73.3
ICD-10 Finland
Stress, not elsewhere classified
9.7
8.8
17
18
WX110
NOMESCO Finland
Local anesthesy
1.8
8.8
365
2921
ZXM20
NOMESCO Finland
Intraoperative use of computerised tomography
20.4
8.5
12
6
WX725
NOMESCO Finland
Noninvasive ventilation
3.5
8.4
39
119
AWB00
NOMESCO Finland
Reoperation for superficial infection in surgery of the nervous system
91.4
8.4
9
*
C71
ICD-10 Finland
Malignant neoplasm of brain
91.4
8.4
9
*
R83
ICPC
Respiratory infection other
0.4
8.4
30
744
9400/3-C71.0
ICD-O-3
Astrocytoma, NOS, of cerebrum
+∞
8.4
8
*
D33.00
ICD-10 Finland
Medial pilosytic astrocytoma of the cerebrum
+∞
8.4
8
*
C71.02
ICD-10 Finland
Malignant tumor of the cerebrum except lobes and ventricles grade III glioma
+∞
8.4
8
*
JN4BD
NOMESCO Finland
Extensive body CT
2.4
8.2
70
315
D69.5
ICD-10 Finland
Secondary thrombocytopenia
33.9
8.1
10
*
TKC20
NOMESCO Finland
Catheterisation of bladder
2.9
8.1
50
185
N19
ICPC
Speech disorder
13.3
7.9
13
10
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
0.5
7.8
96
1557
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
4.1
7.8
29
74
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
4.6
7.7
25
56
SAA01
NOMESCO Finland
Simple examination of mouth
0.6
7.5
228
2963
B01AB10
ATC
tinzaparin; parenteral
2.6
7.4
51
205
9400/3-C71.3
ICD-O-3
Astrocytoma, NOS, of parietal lobe
+∞
7.3
7
*
C71.50
ICD-10 Finland
Malignant tumor of cerebral ventricle without histology
+∞
7.3
7
*
C71.0
ICD-10 Finland
Malignant neoplasm: Cerebrum, except lobes and ventricles
+∞
7.3
7
*
U07.2
ICD-10 Finland
COVID-19, virus not identified
0.3
7.2
16
491
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
2.4
7.1
61
274
205
Kela drug reimbursment
Chronic hypertension
0.5
7.0
51
975
AA5BD
NOMESCO Finland
CT of cerebral ischaemia
5.6
7.0
19
35
G40.2
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
14.0
6.9
11
8
SAA02
NOMESCO Finland
Basic examination of mouth
0.6
6.9
194
2584
R51.80
ICD-10 Finland
Headache
2.1
6.9
78
401
WX892
NOMESCO Finland
Monitored bed care
2.6
6.8
50
205
R41.0
ICD-10 Finland
Disorientation, unspecified
4.2
6.8
24
59
PA7AD
NOMESCO Finland
CT angiography of head and neck vasculature
4.5
6.7
22
50
M25.5
ICD-10 Finland
Pain in joint
0.5
6.5
52
966
C71.09
ICD-10 Finland
Malignant tumor of the cerebrum except lobes and ventricles other or unspecified histology
70.6
6.4
7
*
2151
FHL
Resection, big brain
70.6
6.4
7
*
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.2
6.3
61
292
C71.82
ICD-10 Finland
Overall malignant tumor of the brain grade III glioma
+∞
6.3
6
*
C71.91
ICD-10 Finland
Malignant tumor in unspecified location in the brain grade II glioma
+∞
6.3
6
*
AA003
NOMESCO Finland
Adjuvant radiotherapy of brain
+∞
6.3
6
*
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
2.7
6.3
40
153
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.9
6.2
36
130
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
4.6
6.2
20
45
M75.1
ICD-10 Finland
Rotator cuff syndrome
0.5
6.2
38
769
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
161
29
76.57
294.09
1.8
1.6
—
—
—
0
0
(4035726)
334
405
18.17
286.99
1.3
1.4
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
175
258
9.29
120.38
4.0
10.7
mmol/l
24.1
24.6
1.35
175
244
(3003396) Base excess in Arterial blood by calculation
251
568
7.04
115.59
4.8
8.7
mmol/l
0.9
1.2
1.02
184
456
(3027801) Oxygen [Partial pressure] in Arterial blood
251
569
7.03
115.35
4.8
8.6
kpa
18.5
12.2
28.41
244
549
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
251
569
7.03
115.35
4.8
8.6
kpa
4.9
5.1
4.96
244
546
(3018677) aPTT in Platelet poor plasma by Coagulation assay
271
755
5.88
97.34
1.9
1.9
s
26.5
29.7
14.66
260
732
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
56
32
19.27
69.66
1.0
1.3
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
61
44
15.38
67.40
1.8
1.3
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
44
20
23.73
60.20
1.7
1.4
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
321
1404
3.89
57.31
2.6
2.1
u/l
132.4
212.1
3.43
314
1322
(3044640) Blood type and Crossmatch panel - Blood
319
1479
3.58
50.26
2.1
2.3
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
49
41
12.97
49.41
1.8
1.1
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
265
1130
3.48
47.00
1.9
2.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
355
1814
3.48
46.76
3.2
2.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
66
91
8.06
46.29
1.9
1.3
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
373
2064
3.28
41.07
5.6
6.4
mmol/l
1.2
1.2
6.48
364
1874
(42870588) Differential panel, method unspecified - Blood
312
1559
3.18
41.02
9.3
5.8
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
328
4651
0.32
38.71
2.9
4.5
mmol/l
4.8
4.6
2.89
291
4319
(3033658) Prothrombin time (PT) actual/Normal
256
1183
3.09
37.90
3.5
3.9
%
97.0
90.1
5.60
251
1153
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
342
4734
0.32
37.54
3.1
4.9
mmol/l
3.0
2.8
3.84
300
4363
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
385
2244
3.14
37.29
6.5
7.1
mmol/l
1.2
1.2
2.74
346
1906
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
328
4626
0.33
36.88
3.0
4.4
mmol/l
1.4
1.4
0.03
293
4269
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
62
104
6.56
36.21
1.8
1.2
e6/l
44.2
13.2
0.81
50
83
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
62
104
6.56
36.21
2.0
1.2
e6/l
3939.0
1137.3
0.51
51
87
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
33
28
12.44
32.78
1.6
1.3
mmol/l
2.3
1.9
1.32
28
28
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
30
22
14.33
32.44
1.5
1.2
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
419
2724
2.96
30.31
18.1
9.4
e9/l
4.5
4.1
2.31
378
2409
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
362
2199
2.73
29.61
3.2
4.0
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
37
45
8.72
28.54
2.1
1.4
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
326
4470
0.38
27.88
2.9
4.0
mmol/l
1.3
1.3
0.19
293
4105
(3006504) Eosinophils/100 leukocytes in Blood
354
2194
2.58
26.69
9.7
6.0
%
1.5
2.9
32.70
349
2053
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
28
26
11.27
26.18
1.5
1.2
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
313
4334
0.39
26.07
3.8
5.8
mmol/mol
39.2
40.1
0.91
285
4036
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
340
4528
0.40
25.11
4.0
4.5
mmol/l
6.0
6.0
0.04
300
4142
(3001604) Monocytes [#/volume] in Blood
364
2327
2.52
25.04
9.7
5.8
e9/l
0.5
0.6
4.54
325
2034
(3016502) Oxygen saturation in Arterial blood
133
521
3.02
25.02
6.1
9.1
%
98.2
95.9
13.39
128
502
(3006315) Basophils [#/volume] in Blood
364
2338
2.50
24.61
9.7
5.9
e9/l
0.0
0.0
18.04
323
2051
(3013115) Eosinophils [#/volume] in Blood
370
2413
2.48
23.90
10.2
6.1
e9/l
0.1
0.2
47.59
327
2146
(3019198) Lymphocytes [#/volume] in Blood
363
2384
2.41
22.52
9.9
5.9
e9/l
1.3
1.9
16.09
329
2127
(3032080) INR in Blood by Coagulation assay
312
1921
2.36
22.45
5.2
8.7
inr
1.1
1.2
2.71
85
558
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
27
1280
0.17
22.20
1.3
1.7
mmol/l
1.4
1.4
0.23
22
1075
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
25
26
10.00
21.58
1.3
2.2
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
232
1276
2.37
21.45
1.2
1.4
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
82
269
3.39
20.56
6.7
12.5
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
25
28
9.29
20.44
1.3
2.2
%
16.2
11.6
0.52
11
14
(3011412) CD3 cells [#/volume] in Blood
29
40
7.58
20.09
1.4
2.3
e9/l
0.9
1.2
0.71
24
20
(3020779) Urea [Moles/volume] in Serum or Plasma
104
410
2.87
18.99
1.8
7.0
mmol/l
5.9
9.5
15.30
99
387
(3015377) Calcium [Moles/volume] in Serum or Plasma
254
1518
2.20
18.61
9.4
3.6
mmol/l
2.4
2.3
0.35
237
1340
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
21
23
9.44
17.41
1.1
1.3
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
30
56
5.60
15.58
1.3
1.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
30
57
5.50
15.29
1.3
1.1
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
191
2922
0.48
14.85
2.8
3.0
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
98
424
2.58
14.74
2.2
1.9
nmol/l
300.3
382.8
3.62
88
399
(40758558) Short blood count panel - Blood
198
1163
2.07
14.37
13.6
6.9
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
26
46
5.87
14.26
1.3
1.1
—
—
—
0
0
(3019060) Gas panel - Arterial blood
82
332
2.71
14.06
6.0
6.0
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
79
315
2.75
13.94
7.6
8.4
mmol/l
24.8
24.5
0.51
74
297
(3023368) Bacteria identified in Blood by Culture
216
1324
2.01
13.83
3.3
4.3
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
463
5223
0.43
13.46
38.6
20.9
e9/l
7.3
6.7
6.62
450
5084
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
13
10
13.28
13.41
1.2
1.9
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
463
5222
0.43
13.40
38.6
20.9
e12/l
4.4
4.5
7.43
449
5085
(3035941) MCH [Entitic mass]
463
5221
0.43
13.34
38.4
20.8
pg
30.9
30.4
8.00
458
5148
(3007461) Platelets [#/volume] in Blood
463
5219
0.43
13.22
38.7
20.9
e9/l
231.0
246.3
4.39
452
5091
(3047181) Lactate [Moles/volume] in Blood
50
158
3.37
13.20
7.6
9.7
mmol/l
1.7
1.3
2.10
45
139
(3000991) Gas panel - Venous blood
88
387
2.50
12.71
5.1
9.2
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
13
12
11.06
12.00
1.2
1.9
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
16
738
0.19
11.66
1.1
1.3
u/ml
1.2
10.2
—
6
280
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
15
18
8.53
11.54
1.4
1.1
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
134
739
2.06
11.17
2.0
3.4
mmol/l
0.9
0.8
5.93
127
705
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
45
148
3.21
11.14
2.7
2.6
u/ml
0.4
0.4
0.02
34
82
(3024561) Albumin [Mass/volume] in Serum or Plasma
281
1984
1.81
10.97
5.2
5.1
g/l
34.5
35.6
2.61
269
1849
(3012516) Albumin [Mass/volume] in Urine
68
1402
0.42
10.80
2.7
3.3
mg/l
38.9
231.4
1.55
42
909
(3013707) Erythrocyte sedimentation rate by Westergren method
261
3448
0.56
10.67
2.7
4.1
mm/h
11.3
11.7
0.17
236
3182
(3009508) Creatinine [Moles/volume] in Urine
77
1496
0.44
10.45
2.5
3.1
mmol/l
9.4
7.8
1.15
63
1241
(3001122) Ferritin [Mass/volume] in Serum or Plasma
116
1935
0.50
10.18
2.2
2.7
ug/l
156.4
140.5
0.26
99
1793
(1761868) Lipid panel - Serum or Plasma
96
1696
0.48
9.92
2.2
2.8
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
78
1480
0.45
9.82
3.1
3.9
mg/mmol
10.4
9.2
0.09
39
937
(3026493) Urate [Moles/volume] in Serum or Plasma
58
1231
0.41
9.72
2.1
2.7
umol/l
8766.0
8024.6
0.03
47
1061
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
71
1388
0.44
9.65
1.8
3.0
ng/l
434.7
1256.0
8.52
63
1187
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
13
6
22.12
9.38
1.2
1.2
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
346
4178
0.57
9.35
3.8
4.4
mu/l
1.7
1.9
1.91
312
3792
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
25
775
0.29
9.28
1.1
1.3
iu/ml
12.8
35.0
—
7
237
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
436
3614
1.84
8.99
16.4
7.9
u/l
67.5
78.5
15.15
431
3389
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
113
1825
0.53
8.55
1.9
2.2
nmol/l
76.3
76.1
0.03
102
1629
(3017181) Myelocytes/100 leukocytes in Blood
79
393
2.17
8.50
2.9
4.4
%
1.5
0.9
1.74
42
120
(3018418) pH of Serum or Plasma
200
1359
1.72
8.33
3.2
4.1
ph
7.4
7.4
0.16
36
257
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
10
11
9.23
8.10
1.0
1.3
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
12
18
6.79
7.63
1.2
1.3
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
271
3402
0.62
7.45
3.5
3.7
pmol/l
14.6
14.8
0.59
247
3071
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
124
1887
0.56
7.35
3.1
4.7
ug/l
2.4
2.3
0.08
104
1687
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
133
830
1.78
7.35
3.6
3.2
mmol/l
2.4
2.4
0.42
119
730
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
142
906
1.75
7.26
2.9
3.7
ng/l
232.5
381.8
0.31
100
706
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
14
28
5.10
6.73
1.0
1.0
u/l
1.1
1.1
—
8
17
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
94
1513
0.55
6.65
2.7
4.2
%
21.9
21.3
0.19
40
690
(3021589) Normoblasts [#/volume] in Blood
268
2049
1.57
6.59
15.6
9.5
e9/l
0.0
0.0
0.20
220
1696
(3012501) Base excess in Blood by calculation
28
96
3.01
6.51
2.5
3.5
mmol/l
2.6
2.5
0.05
21
67
(3026008) Bacteria identified in Urine by Culture
182
1284
1.61
6.23
2.4
3.0
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
20
57
3.60
6.21
1.2
2.0
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
11
19
5.88
6.13
1.2
1.2
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
13
27
4.90
6.00
1.2
1.1
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
66
350
2.00
5.98
2.7
4.5
%
0.5
0.4
0.27
23
85
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
26
91
2.94
5.85
2.2
6.8
iu/ml
128.2
250.8
—
6
16
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
10
17
5.97
5.64
1.2
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
10
17
5.97
5.64
1.2
1.2
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
9
7
13.03
5.59
1.1
1.7
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
167
2248
0.64
5.54
2.9
3.5
estimate
0.0
0.0
0.00
32
429
(40761511) CBC panel - Blood by Automated count
445
4884
0.61
5.40
22.4
13.3
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
10
18
5.64
5.34
1.2
1.2
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
13
30
4.41
5.32
1.0
1.0
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
63
1077
0.53
5.30
1.3
1.6
nmol/l
18.8
20.8
0.68
54
917
(3051593) INR in Capillary blood by Coagulation assay
11
22
5.08
5.28
1.8
14.8
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
55
287
2.01
5.22
1.3
1.4
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
14
35
4.07
5.19
1.3
2.1
—
36.4
—
0
5
(4094501)
0
129
0.00
5.15
0.0
1.1
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
130
1828
0.63
5.14
1.7
2.0
pmol/l
95.0
95.3
0.03
67
935
(3021601) Nitrite [Presence] in Urine by Test strip
170
2253
0.65
5.11
4.1
4.8
estimate
0.0
0.0
0.00
32
432
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
12
27
4.52
5.05
3.3
3.2
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
125
1760
0.63
4.93
3.2
3.7
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
66
1085
0.56
4.81
2.2
2.9
ug/l
0.6
0.7
0.87
37
691
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
59
991
0.55
4.62
1.2
1.2
u/ml
0.5
1.8
—
10
273
(3009261) Glucose [Presence] in Urine by Test strip
176
2284
0.67
4.62
3.0
3.6
estimate
0.0
0.0
0.50
31
412
(40768797) Stomach Pathology biopsy report
32
644
0.47
4.38
1.0
1.3
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
9
12
7.60
4.37
1.0
1.4
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
62
1010
0.57
4.33
3.2
3.8
kg/l
1.0
1.0
0.24
17
136
(3021440) Promyelocytes/100 leukocytes in Blood
63
367
1.80
4.32
3.0
4.6
%
0.2
0.1
0.09
38
107
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
8
9
8.99
4.29
1.3
1.0
%
88.4
121.4
—
8
9
(3005322) IgE [Units/volume] in Serum or Plasma
8
266
0.29
4.23
1.0
1.3
u/ml
90.1
279.7
—
8
244
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
30
134
2.31
4.23
1.6
2.3
g/l
3.6
3.6
0.08
30
129
(3029937) Albumin [Presence] in Urine by Test strip
82
1234
0.61
4.20
3.2
3.8
estimate
0.0
0.0
0.50
29
423
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
22
499
0.42
4.12
1.7
1.6
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
34
654
0.49
4.09
1.5
2.3
%
24.6
22.9
0.28
27
562
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
113
781
1.56
4.05
1.8
1.9
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
7
7
10.10
4.02
1.1
1.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
17
424
0.38
3.98
1.5
1.4
—
—
—
0
0
(4010399)
12
352
0.33
3.96
1.0
1.4
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
74
1127
0.61
3.95
1.7
2.0
mg/l
2.8
3.1
0.47
57
968
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
228
1821
1.42
3.92
3.3
3.6
ng/l
17.2
38.2
5.68
182
1282
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
7
8
8.84
3.78
1.1
1.5
—
—
—
0
0
(3019225) pH of Specimen
69
431
1.68
3.73
3.2
4.3
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
45
769
0.55
3.70
1.4
1.4
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
21
464
0.43
3.69
1.2
1.4
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
16
56
2.91
3.65
1.8
1.8
%
89.7
90.1
0.10
16
56
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
33
164
2.07
3.62
1.8
1.7
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
390
4312
0.71
3.62
29.9
15.3
%
39.1
40.4
1.78
280
3137
(3001019) Free T4 and TSH panel - Serum or Plasma
6
211
0.28
3.56
1.2
1.7
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
15
52
2.93
3.48
1.2
2.1
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
167
1286
1.42
3.46
2.4
3.1
e6/l
0.4
0.5
0.26
135
970
(3022145) Colonoscopy Study observation
29
554
0.50
3.42
1.1
1.3
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
181
1417
1.40
3.40
2.5
3.2
e6/l
26.5
111.4
1.13
146
1096
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
9
18
5.06
3.38
1.2
1.1
—
—
—
0
0
(4027681)
10
27
3.75
3.36
1.3
1.2
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
110
1487
0.68
3.31
2.1
2.6
u/l
53.4
56.7
0.76
102
1376
(1616796) Gas panel - Central venous blood
22
96
2.34
3.30
2.0
2.7
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
6
7
8.64
3.27
1.0
1.1
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
406
4437
0.71
3.26
24.2
13.3
ml/min/173m2
91.3
82.0
20.19
369
3664
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
63
947
0.62
3.14
1.4
1.7
pmol/l
485.5
12171065.5
0.79
51
797
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
104
745
1.48
3.13
2.2
3.0
e6/l
3.0
1.8
0.75
66
405
(36304419) Bacteria [Presence] in Urine
161
1251
1.40
3.13
2.3
3.0
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
14
50
2.84
3.10
1.7
2.5
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
11
297
0.36
3.10
1.6
1.4
—
—
—
0
0
(3000492) Spirometry study
24
470
0.49
3.05
1.3
1.4
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
81
557
1.53
2.96
1.7
1.8
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
8
220
0.35
2.85
1.1
1.1
titre
—
95.9
—
0
7
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
81
562
1.51
2.85
1.6
1.8
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
37
616
0.57
2.78
1.5
1.8
%
1.3
1.5
1.13
29
545
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
5
6
8.39
2.75
1.4
1.3
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
75
1050
0.67
2.66
2.6
3.5
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
14
55
2.58
2.63
4.0
4.1
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
20
94
2.17
2.57
1.4
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
20
94
2.17
2.57
1.4
1.4
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
6
11
5.50
2.55
3.0
5.6
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
6
11
5.50
2.55
1.5
2.8
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
6
11
5.50
2.55
1.0
1.3
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
6
11
5.50
2.55
1.5
1.4
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
12
5.04
2.40
1.2
1.1
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
8
22
3.67
2.37
1.3
3.1
%
126.9
88.4
—
8
22
(3007164) IgA [Mass/volume] in Serum or Plasma
64
902
0.67
2.34
1.1
1.5
g/l
2.0
2.6
3.17
32
558
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
103
780
1.39
2.30
2.2
2.8
e6/l
1.5
1.0
0.39
64
434
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
6
173
0.34
2.30
1.5
1.7
—
—
—
0
0
(3026782) Osmolality of Urine
118
915
1.36
2.28
2.2
2.7
mosm/kgh2o
562.2
558.3
0.07
105
781
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
6
14
4.32
2.15
1.3
1.0
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
9
206
0.43
2.11
2.0
2.7
—
—
—
0
0
(3002256) Pathology report gross observation
38
582
0.63
2.06
1.2
1.3
—
—
—
0
0
(3008898) HLA-B27 [Presence]
7
177
0.39
2.06
1.1
1.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
97
1242
0.74
2.02
2.9
3.2
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
198
1680
1.27
1.98
2.6
3.2
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
27
442
0.59
1.94
1.5
1.8
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
0
52
0.00
1.89
0.0
1.3
—
62.6
—
0
41
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
12
52
2.34
1.89
1.1
1.1
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
29
176
1.68
1.83
2.1
1.9
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
129
1048
1.30
1.80
6.4
4.7
—
—
—
0
0
(40768443) Skin Pathology biopsy report
9
192
0.46
1.76
1.0
1.3
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
50
350
1.47
1.74
3.1
4.6
%
0.0
0.1
0.32
25
92
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
0
48
0.00
1.70
0.0
1.4
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
34
509
0.65
1.69
2.1
4.4
ug/l
3.5
33.1
1.17
21
430
(3018095) Leukocytes [#/volume] in Urine
190
1635
1.24
1.64
2.7
3.7
e6/l
38.2
102.0
1.96
149
1177
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
5
132
0.37
1.64
1.4
2.0
pmol/l
252.8
217.6
—
5
122
(1002224) Polysomnography panel
11
223
0.48
1.63
1.1
1.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
11
222
0.49
1.61
1.3
2.0
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
8
174
0.45
1.60
1.1
1.9
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
6
20
3.02
1.58
1.0
1.1
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
8
33
2.44
1.54
3.4
1.3
nmol/l
16.8
20.6
—
8
28
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
32
472
0.66
1.50
1.9
2.0
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
30
448
0.65
1.49
1.7
2.3
nmol/l
15.4
13.1
0.63
24
405
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
6
22
2.74
1.43
2.3
2.2
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
10
46
2.19
1.40
1.3
1.4
promille
0.3
1.2
—
10
37
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
5
120
0.41
1.39
1.2
1.2
—
2.3
—
0
6
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
8
163
0.48
1.37
1.3
4.2
—
1.9
—
0
22
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
8
164
0.48
1.37
1.8
1.6
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
29
427
0.66
1.36
1.8
1.9
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
7
146
0.47
1.33
1.6
1.2
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
0
40
0.00
1.33
0.0
1.4
—
12.0
—
0
13
(3013139) Helicobacter pylori Ag [Presence] in Stool
18
293
0.60
1.32
1.2
1.2
—
—
—
0
0
(3020891) Body temperature
28
185
1.54
1.31
4.4
4.3
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
31
446
0.68
1.31
1.6
2.4
g/l
0.3
0.2
3.60
31
414
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
41
294
1.42
1.30
1.3
1.3
—
37.8
—
0
19
(3025941) Bacteria identified in Stool by Culture
15
255
0.58
1.30
1.5
1.2
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
72
567
1.31
1.29
1.9
2.9
umol/l
6.0
9.0
1.23
63
499
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
41
558
0.71
1.28
1.3
1.5
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
13
227
0.56
1.24
1.0
1.0
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
9
45
2.02
1.23
1.0
1.2
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
20
124
1.63
1.22
1.3
1.7
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
51
663
0.75
1.19
1.3
1.6
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
55
422
1.34
1.19
2.1
3.8
mmol/l
2.2
1.9
0.33
49
335
(3039443) Prostate specific Ag panel - Serum or Plasma
6
130
0.46
1.17
1.7
1.6
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
44
327
1.37
1.16
2.3
2.5
—
21.1
—
0
20
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
10
184
0.54
1.15
1.2
1.9
nmol/l
44.1
38.7
—
10
177
(1617658) Protocol used for examination of sentinel lymph nodes
0
36
0.00
1.14
0.0
1.1
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
5
112
0.44
1.14
1.2
1.7
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
5
114
0.43
1.13
1.2
1.2
—
7.7
—
0
19
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
5
114
0.43
1.13
1.2
1.2
—
2.9
—
0
15
(40761535) Cells panel - Urine sediment
27
386
0.68
1.12
3.3
3.2
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
15
88
1.72
1.12
1.2
1.6
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
7
138
0.50
1.11
1.0
1.1
—
6.5
—
0
17
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
7
31
2.27
1.10
1.3
1.3
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
19
120
1.60
1.10
1.2
1.7
—
—
—
0
0
(4211845)
5
21
2.39
1.09
2.4
3.1
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
45
585
0.75
1.07
3.3
4.4
%
28.6
31.4
1.14
31
383
(40760888) Immunoglobulin light chains.free panel - Serum
6
122
0.49
1.06
1.3
4.4
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
8
147
0.54
1.05
1.5
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
8
148
0.53
1.05
1.5
1.2
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
7
34
2.07
1.03
3.6
2.9
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
5
108
0.46
1.01
1.4
1.4
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
15
235
0.63
0.98
1.5
1.2
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
29
0.00
0.98
0.0
1.0
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
30
0.00
0.97
0.0
1.1
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
0
30
0.00
0.97
0.0
1.4
—
24.0
—
0
5
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
0
30
0.00
0.97
0.0
1.2
—
0.1
—
0
16
(3036603) Volume of Urine
0
31
0.00
0.96
0.0
1.7
—
1858.0
—
0
5
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
0
31
0.00
0.96
0.0
1.6
—
28.6
—
0
5
(3042936) Bacteria identified in Isolate by Culture
58
717
0.79
0.95
1.4
2.1
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
0
32
0.00
0.95
0.0
7.5
—
35.7
—
0
12
(3014271) Vancomycin [Susceptibility]
6
27
2.23
0.93
2.7
2.3
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
21
142
1.50
0.93
1.3
1.7
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
9
154
0.58
0.89
1.1
1.5
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
18
119
1.53
0.89
1.1
1.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
37
282
1.33
0.87
3.1
2.8
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
11
180
0.60
0.87
2.5
1.8
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
46
577
0.78
0.86
1.3
1.4
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
8
44
1.83
0.86
3.7
3.0
—
—
—
0
0
(3013512) EKG study
152
1356
1.16
0.86
3.5
3.8
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
6
31
1.95
0.84
1.5
2.4
—
—
—
0
0
(44806118)
10
58
1.74
0.80
1.1
1.5
—
—
—
0
0
(44790048)
10
58
1.74
0.80
1.1
1.5
—
—
—
0
0
(44790049)
10
58
1.74
0.80
1.1
1.5
—
—
—
0
0
(44790047)
10
58
1.74
0.80
1.1
1.5
—
—
—
0
0
(40768793) Breast Pathology biopsy report
5
98
0.51
0.78
1.2
1.3
—
—
—
0
0
(3017704) Immunofixation for Urine
0
28
0.00
0.76
0.0
1.4
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
11
173
0.63
0.76
1.2
1.3
—
2.0
—
0
10
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
37
289
1.30
0.76
1.6
3.2
mmol/l
1.8
1.7
0.06
32
214
(3044889) 12 lead EKG panel
314
3311
0.89
0.73
3.1
3.8
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
6
110
0.54
0.72
1.3
1.5
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
10
60
1.68
0.72
4.1
2.7
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
12
182
0.65
0.72
1.2
3.1
g/l
7.0
7.3
—
7
140
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
12
182
0.65
0.72
1.2
3.1
g/l
3.4
3.7
—
7
134
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
12
182
0.65
0.72
1.2
3.1
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
29
375
0.76
0.71
2.2
2.7
e9/l
64.4
71.0
0.58
19
289
(3004588) Protein electrophoresis panel - Serum or Plasma
24
319
0.74
0.71
1.1
2.8
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
92
1050
0.85
0.70
1.5
1.7
mg/l
3.1
1.3
1.27
71
794
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
456
4692
0.87
0.70
25.7
14.4
mg/l
17.3
24.0
9.68
436
3726
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
7
118
0.59
0.68
1.4
1.4
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
29
223
1.32
0.68
2.6
3.5
mmol/l
25.5
25.0
0.43
29
217
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
7
43
1.64
0.67
1.3
1.3
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
70
811
0.84
0.65
1.5
1.8
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
70
601
1.19
0.64
8.1
22.5
inr
1.1
1.3
0.93
20
86
(3037467) Urinalysis macro (dipstick) panel - Urine
333
3174
1.12
0.64
3.8
4.2
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
12
79
1.53
0.63
2.6
3.2
e9/l
5.8
4.5
0.47
12
79
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
9
138
0.65
0.61
1.1
2.0
mg/l
32.5
11.9
—
9
127
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
57
483
1.20
0.61
3.8
3.2
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
20
0.00
0.60
0.0
1.3
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
20
0.00
0.60
0.0
1.6
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
20
0.00
0.60
0.0
1.4
—
—
—
0
0
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
0
20
0.00
0.60
0.0
1.3
—
62.3
—
0
13
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
21
0.00
0.60
0.0
1.7
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
22
0.00
0.59
0.0
1.2
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
108
968
1.14
0.59
2.2
2.5
e6/l
6.2
4.4
0.67
100
852
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
23
0.00
0.58
0.0
1.1
—
201.4
—
0
23
(4034850)
10
149
0.67
0.57
6.8
10.5
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
27
340
0.78
0.56
1.3
1.5
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
16
116
1.39
0.55
3.3
4.8
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
6
39
1.54
0.53
1.3
1.7
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
10
66
1.52
0.53
1.2
2.1
—
1744.0
—
0
5
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
23
292
0.78
0.52
1.1
1.2
iu/ml
122.3
153.2
—
5
112
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
14
100
1.41
0.52
1.4
1.5
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
12
83
1.46
0.52
2.8
3.6
%
64.2
57.3
0.73
12
83
(3017143) Hepatitis C virus Ab [Presence] in Serum
47
551
0.84
0.52
1.2
1.6
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
19
144
1.33
0.51
1.6
1.9
%
114.1
88.9
3.55
19
135
(3000093) Morphology [Interpretation] in Blood Narrative
6
41
1.47
0.50
1.0
1.2
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
12
84
1.44
0.49
1.8
1.7
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
7
45
1.56
0.49
2.6
2.5
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
13
93
1.41
0.48
1.2
1.1
u/ml
212.9
279.5
—
8
53
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
16
211
0.75
0.48
2.1
3.7
u/ml
12.9
6101.0
0.70
11
180
(3019832) Treponema pallidum Ab [Presence] in Serum
30
363
0.82
0.46
1.2
1.7
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
33
394
0.83
0.45
2.9
3.7
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
10
69
1.46
0.44
1.3
1.6
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
28
338
0.82
0.43
1.0
1.2
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
12
87
1.39
0.42
1.6
1.8
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
32
380
0.83
0.42
1.8
3.4
g/l
64.9
67.0
0.66
27
347
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
5
32
1.57
0.42
1.0
1.2
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
0
15
0.00
0.41
0.0
1.1
—
37.2
—
0
10
(3035933) Granulocytes/100 leukocytes in Blood
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
0
16
0.00
0.41
0.0
5.4
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
0
16
0.00
0.41
0.0
1.9
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
16
0.00
0.41
0.0
1.1
—
8.9
—
0
16
(3013637) Mi-2 Ab [Presence] in Serum
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
0
17
0.00
0.40
0.0
1.3
—
50.1
—
0
7
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3000919) Neutrophils/100 leukocytes in Pleural fluid
0
17
0.00
0.40
0.0
1.1
—
32.0
—
0
12
(3034891) Synovial lining cells/100 cells in Synovial fluid
0
17
0.00
0.40
0.0
1.2
—
1.0
—
0
5
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
0
18
0.00
0.40
0.0
2.1
—
4105.0
—
0
9
(40768446) Kidney Pathology biopsy report
0
18
0.00
0.40
0.0
1.4
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
7
103
0.68
0.40
1.4
3.1
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
73
808
0.89
0.39
1.6
1.7
nmol/l
1013.0
1202.2
1.25
50
613
(3001893) Eosinophils/100 leukocytes in Pleural fluid
0
19
0.00
0.39
0.0
1.3
—
1.4
—
0
13
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
9
68
1.33
0.37
1.4
1.7
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
17
134
1.28
0.37
4.4
2.9
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
11
146
0.75
0.36
1.2
1.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
33
282
1.18
0.36
1.4
1.6
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
13
99
1.32
0.35
1.1
1.1
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
6
42
1.43
0.35
1.2
1.3
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
46
519
0.88
0.34
2.0
2.6
%
1.8
1.8
0.08
38
469
(3048929) Epstein Barr virus Ab [Presence] in Serum
19
154
1.24
0.34
1.1
1.2
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
6
45
1.34
0.34
1.5
1.3
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
6
86
0.69
0.33
1.0
1.0
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
6
46
1.31
0.33
1.5
1.8
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
6
90
0.66
0.33
1.2
1.0
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
167
1586
1.07
0.31
6.9
3.4
u/l
27.3
32.8
2.94
161
1512
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
7
54
1.30
0.30
1.3
1.7
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
12
93
1.30
0.30
1.1
1.3
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
7
56
1.25
0.29
1.4
1.1
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
12
94
1.28
0.28
1.1
1.3
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
20
237
0.84
0.28
2.0
2.4
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
14
113
1.24
0.27
1.2
1.3
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
67
1.20
0.26
1.5
1.6
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
10
77
1.30
0.26
1.4
1.6
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
5
75
0.66
0.26
1.0
1.1
g/l
1.4
1.5
—
5
69
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
40
359
1.12
0.25
2.0
3.2
ng/l
53.4
188.0
8.86
34
323
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
15
124
1.22
0.24
1.3
1.2
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
7
94
0.74
0.22
1.0
1.6
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
11
0.00
0.21
0.0
10.6
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.0
—
17.9
—
0
10
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
13
0.00
0.21
0.0
10.0
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(4015189)
0
13
0.00
0.21
0.0
2.7
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
0
13
0.00
0.21
0.0
1.1
—
0.8
—
0
7
(3027944) Amphetamines [Presence] in Urine
14
166
0.84
0.20
1.5
1.5
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
52
562
0.92
0.20
8.3
7.3
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
32
355
0.90
0.20
1.1
1.5
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
16
136
1.18
0.20
1.6
1.3
iu/l
18.5
23.2
0.33
16
117
(3048879) Bone marrow aspiration report
0
14
0.00
0.20
0.0
2.1
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
0
14
0.00
0.20
0.0
1.1
—
2.3
—
0
14
(21494434) Karyotype in Bone marrow
6
49
1.23
0.20
1.0
1.1
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
6
49
1.23
0.20
1.5
1.8
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
6
49
1.23
0.20
1.5
1.8
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
6
49
1.23
0.20
1.5
1.8
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
14
165
0.84
0.19
1.6
1.5
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
25
222
1.13
0.19
2.4
2.6
%
0.7
0.7
0.21
25
216
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
49
528
0.92
0.18
2.7
4.1
u/l
270.9
242.6
0.66
44
501
(3003327) Ova and parasites identified in Stool by Light microscopy
11
132
0.83
0.18
2.0
1.4
—
—
—
0
0
(3022313) Gas panel - Capillary blood
25
223
1.13
0.18
1.9
3.2
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
311
3167
0.96
0.17
4.0
3.2
u/l
70.1
51.5
0.91
297
2965
(4306422)
5
69
0.72
0.17
1.0
1.3
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
5
70
0.71
0.16
1.0
2.9
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
23
206
1.12
0.16
4.4
3.7
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
6
76
0.79
0.15
1.0
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
6
76
0.79
0.15
1.0
1.4
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
6
78
0.77
0.15
1.0
1.5
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
7
89
0.78
0.14
1.0
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
7
89
0.78
0.14
1.0
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
7
89
0.78
0.14
1.0
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
7
89
0.78
0.14
1.0
1.4
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
27
249
1.09
0.12
3.3
2.9
e6/l
0.9
0.2
0.51
27
239
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
38
357
1.07
0.11
5.3
2.7
ml/min/173m2
76.7
64.6
1.06
15
144
(3007853) Bacteria identified in Skin by Aerobe culture
57
544
1.05
0.11
1.6
1.7
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
15
167
0.90
0.11
1.5
1.5
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
5
44
1.14
0.10
2.2
1.7
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
15
166
0.90
0.10
1.5
1.5
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
10
114
0.88
0.09
1.2
1.5
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
43
409
1.06
0.09
1.5
2.3
ug/l
3.8
7.1
2.12
36
372
(3016879) Cocaine [Presence] in Urine
14
155
0.90
0.09
1.6
1.5
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
5
61
0.82
0.08
1.2
1.2
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
10
88
1.14
0.08
1.0
1.1
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
8
74
1.08
0.07
1.0
1.1
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
8
75
1.07
0.07
1.9
1.5
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
10
112
0.89
0.07
1.4
1.7
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
7
80
0.87
0.07
1.3
1.1
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
7
85
0.82
0.07
1.1
2.2
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
9
85
1.06
0.07
2.6
1.6
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
8
91
0.88
0.07
2.9
2.2
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
15
160
0.94
0.04
1.5
3.2
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
12
128
0.94
0.02
1.6
1.4
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
13
135
0.96
0.00
1.4
1.3
u/l
7.9
8.3
0.04
13
107
(3050129) First trimester maternal screen panel - Serum or Plasma
10
104
0.96
0.00
1.0
1.4
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
13
134
0.97
0.00
1.2
1.2
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
29
293
0.99
0.00
2.5
3.3
g/l
136.7
128.6
1.51
29
286
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
9
91
0.99
0.00
1.2
2.3
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
8
82
0.98
0.00
1.5
1.1
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
7
71
0.99
0.00
1.1
1.3
mmol/l
7.3
7.4
—
7
50
(3019174) dRVVT (LA screen)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(4268621)
5
56
0.89
0.00
1.8
2.4
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
8
0.00
0.00
0.0
1.3
—
2.0
—
0
8
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
27.0
—
0
5
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
7
0.00
0.00
0.0
2.7
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
7
79
0.88
0.00
1.3
1.1
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
0
8
0.00
0.00
0.0
1.0
—
18.3
—
0
8
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3010370) Gastrin [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.8
—
12.2
—
0
6
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
8
0.00
0.00
0.0
5.9
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
3.4
—
83.8
—
0
8
(3044009) aPTT.lupus sensitive (LA screen)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
0
5
0.00
0.00
0.0
5.4
—
8.0
—
0
5
(3025315) Body weight
0
6
0.00
0.00
0.0
3.3
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
0
8
0.00
0.00
0.0
2.9
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
9
0.00
0.00
0.0
11.3
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
6
66
0.91
0.00
1.2
1.3
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
5
51
0.98
0.00
1.6
1.3
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
104.3
—
0
6
(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
52.4
—
0
5
(3014891) Appearance of Pleural fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_GBM_ASTROCYTOMA – Brain glioblastoma and astrocytoma
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).